Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease: A Prospective Multicenter Randomized Controlled Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02234219
Recruitment Status : Recruiting
First Posted : September 9, 2014
Last Update Posted : September 11, 2019
Sponsor:
Information provided by (Responsible Party):
Jiexiong Feng, Tongji Hospital

Brief Summary:
Comparison of Circular(Soave)and Heart-shaped Anastomosis in Hirschsprung's disease.

Condition or disease Intervention/treatment Phase
Constipation Drug: Probiotics Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease: A Prospective Multicenter Randomized Controlled Trial
Study Start Date : January 2014
Actual Primary Completion Date : July 11, 2019
Estimated Study Completion Date : December 2021


Arm Intervention/treatment
Active Comparator: Circular Anastomosis Drug: Probiotics
Active Comparator: Heart-shaped Anastomosis Drug: Probiotics



Primary Outcome Measures :
  1. Postoperative cure rate [ Time Frame: two years ]

Secondary Outcome Measures :
  1. Postoperative complication rate [ Time Frame: two years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Age<14 years
  2. Hirschsprung's disease diagnosed by biopsy
  3. Surgical indication

Exclusion Criteria:

  1. Age>14 years
  2. Not Hirschsprung's disease
  3. Surgical contraindication

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02234219


Locations
Layout table for location information
China, Hubei
Tongji Hospital Recruiting
Wuhan, Hubei, China, 430030
Contact: Zhi Li, MD PhD    13387664883    lizhimdphd@163.com   
Sponsors and Collaborators
Tongji Hospital
Layout table for additonal information
Responsible Party: Jiexiong Feng, Professor, Tongji Hospital
ClinicalTrials.gov Identifier: NCT02234219    
Other Study ID Numbers: Anastomosis in Hirschsprung
First Posted: September 9, 2014    Key Record Dates
Last Update Posted: September 11, 2019
Last Verified: September 2019
Additional relevant MeSH terms:
Layout table for MeSH terms
Hirschsprung Disease
Constipation
Signs and Symptoms, Digestive
Signs and Symptoms
Digestive System Abnormalities
Digestive System Diseases
Megacolon
Colonic Diseases
Intestinal Diseases
Gastrointestinal Diseases
Congenital Abnormalities